Meet The Team
Dan Copeland
Dan Copeland graduated in 2016 from Vanderbilt University with a B.S.E. in Mechanical Engineering with a capstone project in Biomedical Engineering.
His first exposure to business in medicine was as a summer associate at L.E.K. Boston where he worked on multiple cases within the pharmaceutical industry. Dan’s interest in entrepreneurship, innovation, and medicine continued with his work at the Beth Israel Hospital’s Nazarian Lab. There he conducted research in orthopedics and designed medical devices including novel crutches, wound vacuums, and ventilators.
In 2018, Dan graduated from Tufts Premedical Post-Baccalaureate Program. He is currently an MD candidate at Tufts University School of Medicine.
Karan Sethi
Karan Sethi graduated from North Carolina State University in 2015 with a B.S. Degree in Biology - Integrative Physiology and Neurobiology and a B.S. Degree in Business Administration - Finance.
After graduating, he led clinical and academic research in endocrinology at Duke Hospital. His research projects involved type-2 diabetes and weight loss, familial hypercholesterolemia, and the long-term effects of statins and niacin on atherosclerotic cardiovascular disease. He also helped guide a novel type-2 diabetes micro-learning education study to educate patients on diabetes and insulin use.
Karan is currently an MD/MBA candidate at Tufts University School of Medicine in conjunction with the Heller School for Social Policy and Management at Brandeis University.
Mishan Rambukwella
Mishan Rambukwella graduated from the University of Southern California in 2014 with B.S. and M.S. degrees in Biomedical Engineering.
He obtained his first glimpse into the business side of medicine through coursework in medical device development and an internship in regulatory affairs. After graduation, he worked as a consultant for Accenture in their Health and Public Service practice.
​
Mishan is currently an MD/MBA candidate at Tufts University School of Medicine in conjunction with the Heller School for Social Policy and Management at Brandeis University.
Dan Finch
Dan Finch graduated from Dartmouth College in 2017 with a BA in Biology and Government.
Following graduation, he worked in clinical research at the Massachusetts General Hospital, focusing on sepsis and trauma in the emergency department. He then pursued orthopaedic epidemiology and policy research at the University of Utah in Salt Lake City. He is passionate about evidence based medicine and the integration of data and technology into clinical practice.
Dan is currently an MD/MBA candidate at Tufts University School of Medicine and the Heller School of Social Policy and Management at Brandies University.
Ganeev Singh
Ganeev Singh graduated from the University of California, Los Angeles (UCLA) in 2017 with a B.S. in Psychobiology and minor in Entrepreneurship.
He applied cutting-edge science at the UCLA Hatos Research Center for Neuropharmacology by assisting in developing an open-source optogenetic device in a mouse behavioral paradigm that can be used to activate or inhibit neurons. After graduation, he gained invaluable experience at the intersection of medicine and business by working for Triage Consulting Group in San Francisco. He consulted for hospital clients and dramatically increased their revenues due from insurance companies for patients’ visits.
Ganeev is currently an MD/MBA candidate at Tufts University School of Medicine in conjunction with the Heller School for Social Policy and Management at Brandeis University.
Jacob Rha
Jacob Rha graduated from Baylor University in 2017 with a BBA in Economics and Mathematics with a minor in History.
His interest in the non-clinical aspects of healthcare stem from an econometrics project investigating the effects of environmental and meteorologic factors on suicide rates. As a natural intersection of economics and medicine, he is passionate about healthcare economics and policy analysis.
​
Jacob is currently an MD/MBA candidate at Tufts University School of Medicine in conjunction with the Heller School for Social Policy and Management at Brandeis University.
Arpita Jajoo
Arpita Jajoo graduated in 2019 from Tufts University with a B.S. in Biology.
She was involved in research projects throughout her undergraduate career, leading a project studying the effects of SSRI exposure in early development in the McVey Laboratory at Tufts University and investigating the mechanisms of beta cell death in type one diabetes in the Melton Laboratory at Harvard University. She became interested in the integration of industry and healthcare through work analyzing healthcare sector companies in Tufts Financial Group and pursued that interest during an internship in the finance department of a orphan drug-manufacturing pharmaceutical company.
​
Arpita is currently an MD candidate at Tufts University School of Medicine.